Genomma Lab Internacional, S.A.B. de C.V.
GNMLF
$1.14
$0.054.59%
OTC PK
| 03/31/2025 | 06/30/2024 | 06/30/2024 | 03/31/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 14.72% | 67.21% | 67.21% | 728.30% | 728.30% |
| Total Depreciation and Amortization | -21.31% | -34.51% | -34.51% | 150.64% | 150.64% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 541.41% | 0.57% | 0.57% | 2.39% | 24.88% |
| Change in Net Operating Assets | -216.38% | 35.95% | 35.95% | -263.67% | -249.81% |
| Cash from Operations | -111.55% | 421.00% | 421.00% | -115.94% | -115.94% |
| Capital Expenditure | 37.83% | 65.50% | 65.50% | 26.62% | 26.62% |
| Sale of Property, Plant, and Equipment | -- | 312.47% | 312.47% | -88.04% | -88.04% |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -72.56% | -445.99% | -445.99% | 107.62% | 107.62% |
| Cash from Investing | -125.06% | -201.95% | -201.95% | 91.50% | 91.50% |
| Total Debt Issued | 16.88% | 257.56% | 257.56% | -40.06% | -40.06% |
| Total Debt Repaid | 61.54% | -297.99% | -297.99% | 57.04% | 57.04% |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | 96.63% | -- | -- | 97.79% | 97.79% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -4.87% | -6.91% | -6.91% | -2.87% | -2.87% |
| Other Financing Activities | 6.17% | -13.89% | -13.89% | 2.78% | 2.78% |
| Cash from Financing | 105.16% | 17.21% | 17.21% | 45.53% | 45.53% |
| Foreign Exchange rate Adjustments | -158.62% | 472.73% | 472.73% | -109.08% | -109.08% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -130.31% | 112.64% | 112.64% | -670.09% | -670.09% |